FDA MedWatch - Zaarah Herbals Rasayan Churan, Zaarah Herbals Gurmar Powder, Zaarah Herbals Vasaka Powder and Zaarah Herbals Bhringraj Powder by New York Wholesale Group

If your email program has trouble displaying this email, view as a webpage.

TOPIC: Zaarah Herbals Rasayan Churan, Zaarah Herbals Gurmar Powder, Zaarah Herbals Vasaka Powder and Zaarah Herbals Bhringraj Powder by New York Wholesale Group: Recall - Because of Possible Health Risk

AUDIENCE: Consumer, Health Care Professional, Cardiology, Neurology 

ISSUE: New York Wholesale Group is recalling Zaarah Herbals Rasayan Churan, Zaarah Herbals Gurmar Powder, Zaarah Herbals Vasaka Powder, and Zaarah Herbals Bhringraj Powder because it has the potential to be contaminated with elevated levels of lead and arsenic.

Short term exposures to very low levels of lead may not elicit any symptoms. It is possible that increased blood lead levels may be the only apparent sign of lead exposure. Additional overt signs and symptoms of lead exposure are more likely with acute exposure to higher levels of lead. While lead can affect nearly every bodily system, its effects depend upon the amount and duration of lead exposure and age/ body weight. If a fetus is exposed to enough lead for a protracted period (e.g., weeks to months) permanent damage to the central nervous system may occur. This can result in learning disorders, developmental defects, and other long-term health problems. For adults, chronic lead exposure is associated with kidney dysfunction, hypertension, increased risk of mortality from cardiovascular disease, and neurocognitive effects.

Zaarah Herbals products were distributed to retailers located in New York, New Jersey, Connecticut and California between 12/20/2024 and 01/07/2025. 

The recall is the result of an analysis conducted by Connecticut Department of Consumer Protection; Food & Standards Division that revealed the product contained elevated levels of lead and inorganic arsenic.

To date, no illnesses have been reported.

For more information about this recall, click on the red button "Read Recall" below.

BACKGROUND: Consumption of inorganic arsenic has been associated with cancer, skin lesions, cardiovascular disease, and diabetes in humans. Inorganic arsenic exposure during fetal development, infancy, and childhood may contribute to neurodevelopment effects, as well as increase lifetime cancer risk.

RECOMMENDATIONS: 

• Consumers who have purchased these products should not consume them and can return to the place of purchase for a full refund.

• Consumers with questions may contact the company at 1-800-516-7606.

Health care professionals and consumers are encouraged to report adverse events or side effects related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:

• Complete and submit the report online.
• Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on form, or submit by fax to 1-800-FDA-0178.

Follow us on X at @FDAMedWatch